Huixiang Yang

1.3k total citations
71 papers, 1.0k citations indexed

About

Huixiang Yang is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Huixiang Yang has authored 71 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Pharmacology and 12 papers in Epidemiology. Recurrent topics in Huixiang Yang's work include Microbial Natural Products and Biosynthesis (13 papers), Fungal Biology and Applications (12 papers) and Liver physiology and pathology (9 papers). Huixiang Yang is often cited by papers focused on Microbial Natural Products and Biosynthesis (13 papers), Fungal Biology and Applications (12 papers) and Liver physiology and pathology (9 papers). Huixiang Yang collaborates with scholars based in China, United States and Canada. Huixiang Yang's co-authors include Lijian Tao, Ji‐Kai Liu, Tao Feng, Zheng-Hui Li, Yu Peng, Ying He, Hong Shen, Zhangzhe Peng, Damu Tang and Juan He and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Hepatology.

In The Last Decade

Huixiang Yang

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huixiang Yang China 20 439 166 129 127 124 71 1.0k
Masaki Katayama Japan 18 269 0.6× 89 0.5× 61 0.5× 61 0.5× 190 1.5× 47 1.1k
Fujun Li China 20 607 1.4× 115 0.7× 202 1.6× 78 0.6× 186 1.5× 62 1.3k
Yung‐Yu Hsieh Taiwan 17 387 0.9× 80 0.5× 93 0.7× 139 1.1× 69 0.6× 53 989
Hongfei Tong China 18 392 0.9× 54 0.3× 141 1.1× 99 0.8× 96 0.8× 36 867
Sabine M. Klauck Germany 20 955 2.2× 47 0.3× 155 1.2× 142 1.1× 137 1.1× 58 1.6k
Marie Yeo South Korea 19 376 0.9× 85 0.5× 87 0.7× 94 0.7× 142 1.1× 27 892
Gang Liang China 16 380 0.9× 73 0.4× 117 0.9× 71 0.6× 112 0.9× 50 865
Guangjuan Zheng China 23 588 1.3× 105 0.6× 290 2.2× 196 1.5× 170 1.4× 59 1.3k
C. Richard Boland United States 12 615 1.4× 122 0.7× 318 2.5× 78 0.6× 68 0.5× 28 1.1k

Countries citing papers authored by Huixiang Yang

Since Specialization
Citations

This map shows the geographic impact of Huixiang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huixiang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huixiang Yang more than expected).

Fields of papers citing papers by Huixiang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huixiang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huixiang Yang. The network helps show where Huixiang Yang may publish in the future.

Co-authorship network of co-authors of Huixiang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Huixiang Yang. A scholar is included among the top collaborators of Huixiang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huixiang Yang. Huixiang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Chun, Yuanyuan Feng, Hanqi Zhang, et al.. (2025). Discovery of highly oxygenated cytochalasans with antiproliferative activity from an endophytic fungus Boeremia exigua. Bioorganic Chemistry. 156. 108198–108198. 1 indexed citations
2.
Zhu, Feng, Shuzhen Sun, Ying Zhang, et al.. (2025). Genomic and functional characterization of the Pantoea ananatis nfd35 strain, a potential biocontrol agent of anthracnose disease in Trichosanthes kirilowii Maxim. Physiological and Molecular Plant Pathology. 138. 102683–102683. 1 indexed citations
3.
Hu, Lizhi, Lai Chen, Yong Li, et al.. (2025). The association of proton pump inhibitors and inflammatory bowel disease from the perspective of gut microbiota perturbation. npj Biofilms and Microbiomes. 11(1). 218–218.
5.
Gu, Lei, et al.. (2024). Mefunidone ameliorates acute liver failure in mice by inhibiting MKK4-JNK pathway. Biochemical Pharmacology. 225. 116267–116267. 6 indexed citations
6.
Li, Shenglan, Yan Zhang, Rong Lü, et al.. (2023). Peroxiredoxin 1 aggravates acute kidney injury by promoting inflammation through Mincle/Syk/NF-κB signaling. Kidney International. 104(2). 305–323. 40 indexed citations
7.
Gu, Lei, Shenglan Li, Jie Tang, et al.. (2023). Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway. Biomedicine & Pharmacotherapy. 164. 114844–114844. 15 indexed citations
8.
Wu, Han‐Chung, Huixiang Yang, Zheng-Hui Li, Tao Feng, & Ji‐Kai Liu. (2021). Psathyrellins A–E, Antibacterial Guanacastane Diterpenoids from Mushroom Psathyrella candolleana. Natural Products and Bioprospecting. 11(4). 447–452. 11 indexed citations
9.
Chen, Yao, Huixiang Yang, Zheng-Hui Li, et al.. (2020). Depsidones and diaryl ethers from potato endophytic fungus Boeremia exigua. Fitoterapia. 141. 104483–104483. 14 indexed citations
10.
Chen, Shi, Huixiang Yang, Juan He, et al.. (2020). Chemical constituents and their biological activities from the mushroom Pyropolyporus fomentarius. Phytochemistry. 183. 112625–112625. 14 indexed citations
11.
Yang, Huixiang, et al.. (2020). Indole alkaloids from Ophiorrhiza cantoniensis with immunosuppressive activity. Fitoterapia. 148. 104777–104777. 7 indexed citations
12.
Chen, He‐Ping, Rong Huang, Huixiang Yang, et al.. (2019). Cadinane-type sesquiterpenoids and an indolizine alkaloid from the rice fermentation of the fungus Rigidoporus microporus. Phytochemistry Letters. 32. 119–122. 4 indexed citations
13.
Yang, Huixiang, Wei Li, Hong‐Lian Ai, et al.. (2018). Piperidine alkaloids and xanthone from the roots of Caulophyllum robustum Maxim. Fitoterapia. 132. 22–25. 9 indexed citations
14.
Gu, Yan, Anil Kapoor, Wenjuan Mei, et al.. (2018). Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development. Translational Oncology. 11(4). 1012–1022. 20 indexed citations
15.
Wang, Honghui, Ying He, Hongxian Wang, et al.. (2018). Comparison of TPMT and NUDT15 polymorphisms in Chinese patients with inflammatory bowel disease. World Journal of Gastroenterology. 24(8). 941–948. 32 indexed citations
16.
Xiao, Yun, Yu Peng, Ling Huang, et al.. (2016). GSTA3 Attenuates Renal Interstitial Fibrosis by Inhibiting TGF-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression. PLoS ONE. 11(9). e0160855–e0160855. 21 indexed citations
17.
Liu, Chunyan, Wenjuan Mei, Juan Tang, et al.. (2015). Mefunidone Attenuates Tubulointerstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction. PLoS ONE. 10(6). e0129283–e0129283. 31 indexed citations
18.
Yang, Huixiang, et al.. (2013). Is Urinary Soluble Fas an Independent Predictor of Non-Muscle-Invasive Bladder Cancer? A Prospective Chart Study. Urologia Internationalis. 91(4). 456–461. 13 indexed citations
19.
Tao, Yiming, Jinlin Huang, Shan Zeng, et al.. (2013). BTB/POZ domain-containing protein 7: Epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma. Hepatology. 57(6). 2326–2337. 58 indexed citations
20.
Shen, Liangfang, Shan Zeng, Jia Chen, et al.. (2007). E1A inhibits the proliferation of human cervical cancer cells (HeLa cells) by apoptosis induction through activation of HER-2/Neu/Caspase-3 pathway. Medical Oncology. 25(2). 222–228. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026